She has had an early exit in a device company.ĭr. She has certificates in Translational Medicine from Harvard Medical School, Biopharmaceutical Regulatory Affairs from Northeastern University. She has served as VP of R&D at ZioPharm (Alaunos) and President and CTO at Accurome Health. She was a Professor of Pathology at Harvard Medical School (17 years) and is an Emeritus Pathologist at Beth Israel Deaconess Medical Center and Harvard Medical School. She has a graduate certificate from Harvard Business School on Program in Leadership Development. in Genetics and Molecular Biology from University of North Carolina, Chapel Hill and carried out her Postdoctoral Fellowship at Massachusetts Institute of Technology in Cancer Immunology. She is an experienced entrepreneur and has led successful translational programs in research and development over the last 30 years in both academia and industry. Roya Khosravi-Far, Ph.D., PLD, InnoTech, co-founder, President and Chief Executive Officer is passionate about translating bench-side discoveries to bed-side realities. He also was involved with another startup diagnostic company with Dr. Roya Khosravi-Far that was sold to GT Advanced Technologies in 2015. He cofounded an equipment company that was sold to Veeco Corporation in 2005 and was a founder of another technology company with Dr. He has 5 patents on unique equipment and device designs. He has worked on and lead projects that range from developing optical coatings to Infrared sensors and ceramic transducers. He has experiences in a vast array of micro and nanofabrication processes and device engineering. He has also served as the Director of Northeastern University’s Nano manufacturing facility for eight years with programs including biosensor development with nanomaterial. Among other recent roles that he has held are leadership roles at Draper Labs in Cambridge, MA, directing and managing the workflow and process at the biology and MEMS facilities. He has held positions as Principal Engineer at Reytheon, designing and optimizing manufacturing processes for a variety of devices including medical devices a Principal Engineer at MKS, where he was involved in managing the workflow of the processes for manufacturing of chips for EUA authorized COVID-19 tests for some of their customers. He has over 30 years of experience in nanotechnology and MEMs research and development, process and product development, manufacturing and leadership. Rich is a physicist by education and engineer by training. Richard DeVito, M.S., co-founder, and Principal Engineer, received his M.S. in Engineering Science from the University of Miami in Chemical Engineering from Columbia University, and a B.S. in Chemical/Biochemical Engineering from Rutgers University, M.S. Dr Aparicio is active in his community by participating as member of advisory committees for University of Miami Biomedical Engineering Department, Miami-Dade Community College, Cystic Fibrosis Foundation, Hialeah Technology Center, and Greater Ft Lauderdale Chamber of Commerce. In addition, he is currently a Technical Lead for the NIH/RADx-Tech program for the rapid development of diagnostic tests for Covid-19, advising diagnostic companies in their development and commercialization strategies. Prior to CLAS Automation, Dr Aparicio held C-level positions and worked in product development for ImmunoSite Technologies, Abbott, Beckman-Coulter, Warner-Lambert, and Ciba-Geigy. Prior to joining InnoTech Precision Medicine, he served as CEO & President of CLAS Automation, Inc., a world-renowned provider of laboratory automation services to Clinical Research Organizations (CROs), pharmaceutical companies, and academia. Carlos Aparicio, PhD, InnoTech, Chief Operating Officer has more than 25 years of leadership experience in the pharmaceutical and medical devices industries.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |